AuroMedics Pharma LLCUsage: Ibandronate sodium injection is indicated for treating postmenopausal osteoporosis, enhancing bone mineral density and reducing vertebral fractures. Its safety and effectiveness are based on one year of clinical data, with the need for continued therapy to be re-evaluated periodically. Consider discontinuation for low-risk fracture patients after 3-5 years.